CIK 0001022079
- Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 161387862
- Phone
- +1 973-520-2700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,794,069
- in 6 filings, $19.8M under 10b5-1 plans
Net −$19,794,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Deppe Michael J −$3.1M SVP, Corp. Controller & CAO sold 25% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-24 | GUINAN MARK Executive Vice President & CFO | Sale | −22,563 | $121.18 | $2.7M | 73,579 |
| 2020-12-24 | GUINAN MARK Executive Vice President & CFO | Option exercise · Non-Qualifed Stock Option (right to buy) | −81,756 | $66.51 | $5.4M | 0 |
| 2020-11-24 | WILENSKY GAIL R Director | Option exercise | +6,111 | $57.67 | $352K | 22,593 |
| 2020-11-24 | WILENSKY GAIL R Director | Sale | −6,111 | $126.02 | $770K | 16,482 |
| 2020-11-24 | WILENSKY GAIL R Director | Option exercise · Stock Options (Right to Buy) | −6,111 | $57.67 | $352K | 0 |
| 2020-11-23 | STANZIONE DANIEL Director | Sale | −5,621 | $125.73 | $707K | 33,951 |
| 2020-11-23 | STANZIONE DANIEL Director | Sale | −3,302 | $126.46 | $418K | 30,649 |
| 2020-11-23 | STANZIONE DANIEL Director | Sale | −2,300 | $127.45 | $293K | 28,349 |
| 2020-10-21 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Option exercise | +4,750 | $56.82 | $270K | 29,785 |
| 2020-10-21 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Option exercise | +5,700 | $57.61 | $328K | 35,485 |
| 2020-10-21 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Sale | −5,700 | $125.00 | $713K | 29,785 |
| 2020-10-21 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Sale | −4,750 | $125.00 | $594K | 25,090 |
| 2020-10-21 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Option exercise · Non-Qualifed Stock Option (right to buy) | −4,750 | $56.82 | $270K | 0 |
| 2020-10-21 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Option exercise · Non-Qualifed Stock Option (right to buy) | −5,700 | $57.61 | $328K | 0 |
| 2020-10-16 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Option exercise | +291,997 | $66.51 | $19.4M | 529,744 |
| 2020-10-16 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Sale | −291,997 | $120.00 | $35.0M | 237,747 |
| 2020-10-16 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Option exercise · Non-Qualifed Stock Option (right to buy) | −291,997 | $66.51 | $19.4M | 0 |
| 2020-10-14 | PREVOZNIK MICHAEL E SVP & General Counsel | Option exercise | +35,591 | $52.17 | $1.9M | 75,678 |
| 2020-10-14 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | −35,591 | $119.00 | $4.2M | 40,087 |
| 2020-10-14 | PREVOZNIK MICHAEL E SVP & General Counsel | Option exercise · Stock Options (Right to Buy) | −35,591 | $52.17 | $1.9M | 0 |
Page 39 of 42 · 826 trades